45
Ca outflow, membrane potential, [Ca 2+ ] i , insulin release in secretory cells as well as measurements of smooth muscle contractile activity and glycaemia were carried out. Results. The analogue BPDZ 73 induced a dose-dependent decrease in insulin output. The IC 50 value averaged 0.73 0.05 mmol/l. The drug increased the rate of 86 Rb ( 42 K substitute) outflow from perifused rat pancreatic islets. This effect was inhibited by glibenclamide, a K ATP channel blocker. Measurements of DiBAC 4 (3) fluorescence further indicated that BPDZ 73 hyperpolarised the insulin secreting cells. It also decreased 45 Ca outflow from pancreatic islets perifused throughout in the presence of 16.7 mmol/l glucose and extracellular Ca 2+ . By contrast, the drug did not affect the increase in 45 Ca outflow mediated by K + depolarisation. In single beta cells, BPDZ 73 inhibited the glucose-induced but not the K + -induced rise in [Ca 2+ ] i . Moreover, in Wistar rats, i. p. injection of BPDZ 73 provoked a considerable increase in blood glucose concentration whereas diazoxide induced a modest rise in glycaemia. Lastly, the vasorelaxant properties of BPDZ 73 were slightly less pronounced than those of diazoxide. Conclusion/interpretation. The inhibitory effect of BPDZ 73 on the insulin-releasing process results from the activation of K ATP channels with subsequent decrease in Ca 2+ inflow and [Ca 2+ ] i . The drug seems to be a K ATP channel opener, more potent and more selective than diazoxide for insulin secreting cells. [Diabetologia (2000) 43: 723-732] Keywords Diazoxide, ATP sensitive K + channel, rat pancreatic islets, insulin release.
suggest that modifications in endogenous insulin secretion rate, as induced by diazoxide, can alleviate or prevent several diseased states involving altered endocrine pancreatic function.
A pharmacological route to interfere with the insulin secretory process is to develop compounds acting at the level of the ATP-sensitive K + (K ATP ) channel. These channels, heteromultimers composed of sulphonylurea receptor (SUR1) and Kir6.2 subunits [9] , equip the beta-cell plasma membrane and couple the cellular metabolism to electrical activity. The closing of beta-cell K ATP channels initiates membrane depolarisation and thereby eventually leads to exocytosis of secretory granules whereas the activation of K ATP channels promotes membrane hyperpolarisation and decreases insulin release [10, 11] .
According to their tissue localisation and their SUR subunit type, the sensitivity of K ATP channels to pharmacological agents vary widely [9, 11, 12] . In the search for new K ATP channel modulators with fewer side effects than diazoxide [1, 7] , we recently synthesised 7-chloro-3-isopropylamino-4H-1,2,4-benzothiadiazine 1,1-dioxide (BPDZ 73). This compound corresponds to a diazoxide analogue having the methyl side chain in the 3-position of the heterocycle replaced by an isopropylamino group (Fig. 1) . The present study aims at evaluating the in vivo and in vitro effect of BPDZ 73. Because the drug was found to be much more potent than diazoxide at increasing the blood glucose concentration and at reducing the glucose-induced insulin release from rat pancreatic islets, additional experiments were conducted to characterise the selectivity and the mechanism of action of BPDZ 73.
Materials and methods
Measurements of insulin release from incubated pancreatic islets. Experiments were done with pancreatic islets isolated by the collagenase method from fed albino rats. The laboratory animal care was approved by the ethics committee of the FREE University of Brussels.
Groups of ten islets, each derived from the same batch of islets, were preincubated for 30 min at 37°C in 1 ml of a bicarbonate-buffered solution (in mmol/l: 115 NaCl, 5 KCl, 2.56 CaCl 2 , 1 MgCl 2 , 24 NaHCO 3 ) supplemented with 2.8 mmol/l glucose, 0.5 % (w/v) dialysed albumin (fraction V) and equilibrated with a mixture of O 2 (95 %) and CO 2 (5 %). The islets were then incubated at 37°C for a further 90 min in 1 ml of the same bicarbonate-buffered medium containing 16.7 mmol/l glucose and, in addition, increasing concentrations of BPDZ 73. Individual experiments were carried out as quadriplicate measurements with the values corresponding to the number of samples pooled. Due to the islet-related variations, insulin release was expressed as a percentage of the value recorded in control experiments (100 %), i. e. in the absence of drug and presence of 16.7 mmol/l glucose. The release of insulin was measured radioimmunologically as reported previously [13] .
Measurements of 86
Rb, 45 Ca outflow and insulin release from perifused pancreatic islets. Experiments were done with pancreatic islets isolated by the collagenase method from fed albino rats.
The Ca ion (0.02± 0.04 mmol/l; 3.70 10 6 Bq/ml). After incubation, the islets were washed four times with a non-radioactive medium and then placed in a perifusion chamber. The perifusate was delivered at a constant rate (1.0 ml/min). From the 31st to the 90th min of perifusion, the effluent was continuously collected over successive periods of 1 min each. An aliquot of the effluent (0.5 ml) was used for scintillation counting (last tube never below 250 cpm) and the remainder was stored at ±20°C for insulin radioimmunoassay [13] . At the end of the perifusion, the radioactive content of the islets was also determined. The outflow of 86 Rb or 45 Ca ion (cpm/min) was expressed as a fractional outflow rate (% of instantaneous islet content/min; FOR). The validity of 86 Rb as a tracer for the study of K + handling in pancreatic islets has been assessed previously [18] .
Measurements of DiBAC 4 (3) fluorescence from b-TC3 cells. Insulin-producing b-TC3 cells, a glucose-responsive beta-cell line [19] , were cultured to about 80 % confluency in black-walled microtitre plates [96-well format, tissue treated, View-Plate (Packard, Meriden, Conn., USA)]. The b-TC3 cells were maintained in DMEM containing, in addition, glutamax-1 (l-alanyl-l-glutamine 0.862 mg/ml), sodium pyruvate (110 mg/ml), pyridoxine (4 mg/ml), glucose (25 mmol/l), non-essential amino acids, fetal calf serum (15 %), penicillin (100 U/ml) and streptomycin (100 mg/ml) (Life Technologies, Merelbeke, Belgium) [19] . After washing and pre-incubation at 37°C in a modified Krebs-Ringer-HEPES buffer (in mmol/l: NaCl 140, KCl 3.6, NaH 2 PO 4 0.5, MgSO 4 0.5, NaHCO 3 2.0, CaCl 2 1.5, dglucose 10 and HEPES 10; pH 7.4), the cells were incubated in the same buffer with the addition of 4 mmol/l of the membrane-potential sensitive dye bis-(1,3-dibutylbarbituric acid) trimethine oxonol (DiBAC 4 (3)) [20] (Molecular Probes, Eugene, Ore., USA). The plates were then placed on a programmable stage fitted to a Nikon TMD microscope equipped with a 20´NA 0.5 Fluar objective. The cells in the microtitre plate were first allowed to equilibrate with the added probe. Thereafter, the cells in the field of view from one well in the plate were excited at 470 6 nm at 1 Hz for 20 s. During this time, a sample of BPDZ 73 or diazoxide was added to the well as a 2´concentrated solution in buffer with DiBAC 4 (3) . Emitted fluorescence from the cells in the well was measured and averaged for the time 3 to 5 s immediately after addition. By an automated procedure, the fluorescence from the same field of cells in the well was again measured 45 min later. At this time, no addition was made but the average signal during 3 s of the total 20 s recording time was extracted. This procedure was repeated for each of the 96 wells of the microtitre plate in succession. For each compound and concentration, a total of six to eight individual wells were used to construct the data sets (Fig. 4) . Total time for the measurement of one plate was 90 min but each well was incubated with compound for 45 min. We used Microsoft Excel and MacCurveFit 1.4 (Microsoft, Redmond, Wash., USA) to process the data which are expressed as the change in DiBAC 4 (3) fluorescence during the 45 min of incubation. Because the number of cells in the field of view in the microscope varied from well to well by a factor of 2±3, the changes in fluorescence were normalised individually to the initial reading for each well.
Measurements of fura-2 fluorescence from single rat pancreatic islet cells. Pancreatic islets were disrupted in a Ca 2+ -deprived medium and then centrifuged through an albumin solution to remove debris and dead cells. Cells were seeded onto glass coverslips and maintained in tissue culture for 72 h before use. Islet cells were cultured in RPMI 1640 culture medium (Life Technologies) supplemented with 10 % (v/v) newborn calf serum and containing glutamine (2.3 mmol/l), glucose (16.7 mmol/l), penicillin G (100 U/ml) and streptomycin (100 mg/ml). The cells were then incubated with fura-2 AM (2 mmol/l) (Molecular Probes) for 1 h and, after washing, the coverslips with the cells were mounted as the bottom of an open chamber (1 ml) placed on the stage of the microscope. The medium used to perifuse the cells contained (in mmol/l) NaCl 115, KCl 5, CaCl 2 2.56, MgCl 2 1, NaHCO 3 24, glucose 2.8 and was gassed with O 2 (95 %):CO 2 (5 %). Fura-2 fluorescence of single-loaded cells was measured by use of dual-excitation microfluorimetry with a Spex photometric system (Optilas, Alphen aan den Rijn, Holland). The excitation wavelenghts (340 nm and 380 nm) were alternated at the frequency of 1 Hz. The emission wavelength was set at 510 nm. We calculated [Ca 2+ ] i as described previously [17] . Individual experiments were repeated at least four times, on different cell populations.
Measurements of mechanical activity of rat aortic rings. Experiments were conducted as described previously [21] . Aortas were removed from fed albino rats and cut into transverse rings (3±4 mmol/l long). The endothelium was removed by rubbing the intimal surface with forceps. The segments were suspended under 1-g tension by means of steel hooks in an organ bath containing a bicarbonate-buffered solution of the following composition (in mmol/l): NaCl 118, KCl 4.7, CaCl 2 2.5, NaHCO 3 25, KH 2 PO 4 1.2, MgSO 4 1.2, glucose 5. The solutions were maintained at 37°C and bubbled continuously with a mixture of O 2 (95 %) and CO 2 (5 %). The isometric contractions were measured with a grass-force displacement transducer. After 60 min of equilibration, the rings were exposed to 30 mmol/l KCl. When the tension had stabilised, increasing concentrations of either diazoxide or BPDZ 73 were added to the organ bath until maximum relaxation.
Measurements of glycaemia. Adult albino rats weighing 300±350 g were allowed to settle in for at least 3 days in the laboratory before use. They had free access to water and received a standard pellet diet. Conscious rats were placed for 60 min before blood sampling and throughout the duration of the study in a small cabinet. Drugs were dissolved in a sterile physiological sodium salt solution (NaCl 0.9 %) supplemented with NaOH. At zero time, 20 mg/kg of diazoxide or BPDZ 73 were injected intraperitoneally (i. p.). Control animals received an equivalent volume of NaCl 0.9 % supplemented with NaOH; 5 ml × kg ±1 body weight. Blood was taken from the tail at time ±5 min, 30 min, 60 min, 90 min, 120 min and 180 min. Blood glucose concentration was measured, in duplicate, using a reagent strip in combination with a glucometer (Accutrend, Boehringer-Mannheim, Mannheim, Germany).
Drugs. In some experiments, extracellular Ca 2+ was eliminated by the omission of CaCl 2 from the physiological medium and the addition of 0.5 mmol/l ethylene glycol-bis (b-aminoethyl ether)N,N¢-tetra-acetic acid (EGTA; Sigma-Aldrich, Bornem, Belgium). According to the experiments, the media were enriched with glucose (Merck, Darmstadt, Germany), glibenclamide (Hoechst Roussel, Brussels, Belgium), diazoxide (Sigma-Aldrich), verapamil hydrochloride (Knoll, Ludwigshafen, Germany) or BPDZ 73.
The BPDZ 73 was synthesised at the Department of Medicinal Chemistry, University of Lige, Belgium. The IR spectrum was recorded as a KBr pellet on a Perkin-Elmer 1750FT-spectrophotometer (Perkin Elmer, Beaconfield, UK). The proton NMR spectrum was taken on a Bruker AW-80 (80 MHz) instrument (Bruker, Karlsruhe, Germany). The compound was obtained as described previously for structural analogues [22, 23] For the in vitro experiments, glibenclamide, diazoxide and BPDZ 73 were dissolved in dimethylsulphoxide which was added to both control and test media. At the final concentrations used, dimethylsulphoxide fails to affect islet function and smooth muscle contractility [17, 21, 26] . When high concentrations of extracellular K + were used, the concentration of extracellular NaCl was lowered to keep osmolarity constant.
Calculations. Results are expressed as the means ( SEM).
The magnitude of the increase in 86 Rb and 45 Ca outflow was estimated in each individual experiment from the integrated outflow of 86 Rb or 45 Ca observed during stimulation (45th-68th min) after correction for basal value (40th-44th min). The inhibitory effect of BPDZ 73 on 45 Ca outflow and insulin release was taken as the difference between the mean value for 45 Ca outflow or insulin output recorded in each individual experiment between the 40±44th and 60±68th min of perifusion. The IC 50 value for insulin release (concentration giving a 50 % reduction of the secretory response to 16.7 mmol/l glucose) was assessed graphically. For the rat aortic rings, the relaxation responses were expressed as the percentage of the contractile responses to KCl. The efficacy dose 50 % (ED 50 ) values were graphically assessed for each dose response curve as the concentration evoking 50 % inhibition of the sustained contraction induced by KCl. The statistical significance of differences between mean data was assessed by use of Student's t test or by analysis of variance followed for multiple comparisons by a Scheffe is test procedure. A p value less than 0.05 was considered significant.
Results
Chemical synthesis of BPDZ 73. The BPDZ 73 ( Fig. 1) was obtained from the reaction of an excess of isopropylamine with 7-chloro-3-methylsulphanyl-4H-1,2,4-benzothiadiazine 1,1-dioxide, a useful synthetic intermediate in the access way to 3-alkylamino-substituted benzothiadiazine 1,1-dioxides [22, 23] . The synthesis of the 3-methylsulphanyl-substituted intermediate was done in three steps starting from 4-chloroaniline and following methods described previously [24, 27] .
Effects of BPDZ 73 and diazoxide on insulin release from glucose-stimulated rat pancreatic islets. The addition of increasing concentrations of BPDZ 73 provoked a dose-dependent decrease in insulin output from rat pancreatic islets incubated in the presence of 16.7 mmol/l glucose (Fig. 2) . After the addition of 0.1 mmol/l, 1 mmol/l and 10 mmol/l BPDZ 73 to the incubation medium, the insulin release represented 90. Previous investigations indicated that, under the same experimental conditions, the IC 50 value for the inhibitory effect of diazoxide on insulin release amounted to 24.8 3.4 mmol/l [17] .
Effects of BPDZ 73 on 86
Rb outflow from perifused rat pancreatic islets. In the presence of 5.6 mmol/l glucose in the basal medium, the addition of BPDZ 73 Rb outflow from pre-labelled and perifused rat pancreatic islets (Fig. 3) . The integrated outflow of 86 Rb measured during exposure to the drug averaged 0.10 0.05 %/min after addition of 1 mmol/l; 1.42 0.13 %/min after addition of 10 mmol/l and 2.43 0.23 %/min after the addition of 50 mmol/l BPDZ 73, respectively (p < 0.05 in each case). The withdrawal of the drug from the perifusate was accompanied by a decrease in 86 Rb FOR. When the physiological medium was enriched with the hypoglycaemic sulphonylurea glibenclamide (10 mmol/l); the stimulatory effect of 1 mmol/l (data not shown), 10 mmol/l (data not shown) and 50 mmol/l BPDZ 73 (Fig. 3) was completely abolished.
In islets exposed throughout to 16.7 mmol/l instead of 5.6 mmol/l glucose, 10 mmol/l BPDZ 73 again elicited a rapid, sustained and reversible increase in the rate of 86 Rb outflow (data not shown). Under these experimental conditions the stimulatory effect of BPDZ 73 (10 mmol/l) only represented, however, 44.8 9.5 % of that recorded in the presence of 5.6 mmol/l glucose in the perifusate (p < 0.05).
Effects of BPDZ 73 and diazoxide on b-TC3 membrane potential. Qualitative changes in membrane potential were assessed in the insulin-producing cell line, b-TC3, by measuring DiBAC 4 (3) fluorescence (Fig. 4) . The addition of BPDZ 73 was found to provoke a concentration-dependent hyperpolarisation of the cells incubated in the presence of 10 mmol/l glucose.
Under the same experimental conditions, diazoxide also hyperpolarised the cells. Diazoxide was, however, clearly less potent than BPDZ 73 at increasing membrane potential. Thus, diazoxide had an EC 50 value of 77.4 4.3 mmol/l and BPDZ 73 an EC 50 value of 2.2 0.6 mmol/l.
Additional experiments conducted on discrete mouse beta cells in the context of a whole pancreatic islet produced ED 50 values for the two compounds in the same range as those found in b-TC3 cells. The ED 50 value for BPDZ 73 was found to be about 1 mmol/l in four experiments and the value for diazoxide was about 90 mmol/l in two experiments (data not shown).
Effects of BPDZ 73 on 45
Ca outflow and insulin release from perifused rat pancreatic islets. When the physiological medium contained 16.7 mmol/l glucose and extracellular Ca 2+ , the addition of BPDZ 73 provoked an immediate and pronounced inhibition of 45 Ca outflow (Fig. 5) . The inhibitory effect of the drug was reversible and concentration-dependent. Thus, the paired difference in 45 Ca FOR before (min 40±44) and during (min 60±68) exposure to 1 mmol/l and 10 mmol/l BPDZ 73 averaged 0.68 0.07 %/min and 0.87 0.04 %/min, respectively (p < 0.05). The withdrawal of the drug from the perifusing medium was accompanied by an increase in 45 Ca outflow. The latter increase was more rapid after the removal of the lower drug concentration (Fig. 5) .
To further investigate the effects of BPDZ 73 on 45 Ca movements, similar experiments were done in the presence of 16.7 mmol/l glucose but absence of extracellular Ca
2+
. In islets exposed to Ca 2+ -depleted media, the basal rate of 45 Ca outflow (min 40±44) was lower (0.69 0.02 %/min, n = 8, p < 0.05) and the addition of either 1 mmol/l or 10 mmol/l BPDZ 73 did not affect 45 Ca FOR (data not shown). The addition of 1 mmol/l BPDZ 73 also failed to modify the rate of 45 Ca outflow from islets perifused in the presence of a Ca 2+ -free solution containing 5.6 or 8.3 mmol/l glucose throughout (n = 4 in each case; data not shown). ) in fluorescence, were normalised to the initial reading for each well and given as mean SEM. The smooth curves were computed using a four-parameter non-linear curve-fitting algorithm reduced to three parameters by fixing the Hill slope to ±1.5 for both curves. During the fitting procedure, the data points were weighted inversely to their respective SEM values. The predicted bottom level for the diazoxide curve was ±0.42 using this approach and seems to be reasonable when compared with the maximum effect of BPDZ 73. Measurements above 300 mmol/l diazoxide were avoided due to solubility problems with the compound Increasing concentrations of BPDZ 73 provoked an immediate, sustained and concentration-dependent inhibition of insulin output from islets exposed to 16.7 mmol/l glucose and extracellular Ca 2+ (Fig. 5) . During exposure to 1 mmol/l and 10 mmol/l BPDZ 73 (min 60±68), the release of insulin represented, respectively, 40.43 1.19 % and 10.63 1.63 % of that recorded before treatment with the drug (min 40±44) (p < 0.05). The removal of 1 mmol/l BPDZ 73 was followed by a rapid increase and the omission of 10 mmol/l BPDZ 73 resulted in a delayed increase in insulin output (Fig. 5) .
In another series of experiments, we characterised the effects of BPDZ 73 on the secretory response induced by a sudden increase in the extracellular glucose concentration. A rise in the glucose concentration from 5.6 to 16.7 mmol/l provoked a rapid and sustained insulin output (Fig. 6) . When the same experiment was repeated in the presence of 1 mmol/l BPDZ 73 throughout, the basal rate of insulin release (min 40±44) was unaffected (p > 0.05) but the secretagogue action of 16.7 mmol/l glucose was almost completely abolished (Fig. 6) . The integrated output of insulin measured during exposure to 16.7 mmol/l glucose and corrected for basal values (min 40±44), averaged 0.82 0.11 mU × min ±1 × islet ±1 in the absence and 0.13 0.02 mU × min ±1 × islet ±1 in the presence of 1 mmol/l BPDZ 73, respectively (p < 0.05).
Effects of BPDZ 73 and verapamil on KCl-induced changes in 45
Ca outflow from perifused rat pancreatic islets. In the absence of glucose and presence of Ca 2+ in the medium, a sudden rise in the extracellular concentration of K + provoked an immediate and pronounced increase in 45 Ca outflow from perifused islets (Fig. 7) . When the same experiment was repeated in the presence of BPDZ 73 (10 mmol/l and 50 mmol/l) in the perifusate, the basal rate of 45 Ca outflow was unaffected (p > 0.05) (Fig. 7) . Moreover, BPDZ 73 did not affect the cationic response to 50 mmol/l K + (Fig. 7) . Indeed, the integrated outflow of 45 Ca observed during exposure to 50 mmol/l K + averaged 0.96 0.05 %/min in the absence, 0.98 0.08 %/min in the presence of 10 mmol/l BPDZ 73 and 0.85 0.09 %/min in the presence of 50 mmol/l BPDZ 73, respectively (p > 0.05 in each case).
For comparison, we characterised the effect of the Ca 2+ channel blocker verapamil [28] on the cationic response to high extracellular K + (Fig. 7) . The presence of verapamil (10 or 50 mmol/l) in the perifusing medium provoked a concentration-dependent de- 45 Ca outflow evoked by K + averaged 1.11 0.07 %/min in the absence and 0.60 0.06 %/ min in the presence of 10 mmol/l verapamil (p < 0.05). In islets exposed throughout to 50 mmol/l verapamil, the stimulatory effect of K + was short-lasting and greatly reduced.
Effects of BPDZ 73 on the cytosolic free Ca 2+ concentration of single rat pancreatic islet cells. Raising the extracellular glucose concentration from 2.8 to 16.7 mmol/l provoked an initial decrease followed rapidly by a pronounced and sustained rise in [Ca 2+ ] i (Fig. 8) . The addition of BPDZ 73 (1 mmol/l) during the 16.7 mmol/l glucose stimulation reduced the cytosolic free Ca 2+ concentration (Fig. 8) . The inhibitory effect of BPDZ 73 was rapid, pronounced and reversible. Similar results were recorded with 10 mmol/l BPDZ 73, except that the inhibitory effect of the compound was less rapidly reversible (data not shown).
By contrast, BPDZ 73 (1 mmol/l) did not affect the rise in [Ca 2+ ] i induced by 50 mmol/l K + (Fig. 8) .
Effects of diazoxide and BPDZ 73 on the contractile activity of rat aortic rings. In rat aortic rings, a rise in the extracellular concentration of K + provoked an increase in muscle tension which, after a few minutes, reached a plateau phase.
When a sustained contraction was obtained, the cumulative application of diazoxide or BPDZ 73 to the bathing medium induced concentration-dependent relaxations (Fig. 9) . The relaxant potency of diazoxide, as calculated from the EC 50 value, was, however, higher than that of BPDZ 73 (p < 0.05). Thus, the EC 50 value for diazoxide amounted to 22.0 2.6 mmol/l whereas the EC 50 value for BPDZ 73 amounted to 36.3 2.2 mmol/l.
Effects of BPDZ 73 and diazoxide on blood glucose concentration. In control rats receiving the vehicle, there was a continuous and small decrease in blood glucose concentration (Fig. 10) . The glycaemia averaged 145.0 4.5 mg/100 ml at time ±5 min and 126.3 6.3 mg/100 ml at the 180th min.
Treatment with the solution of diazoxide provoked a modest increase in blood glucose concentration peaking at the 60th min at 206.1 7.60 mg/100 ml (p < 0.05) (Fig. 10) . At the 180th min, the blood glucose concentration was no more significantly different from its initial value (±5 min) (p > 0.05).
The changes in blood glucose resulting from treatment with BPDZ 73 were much more pronounced than those induced by diazoxide (Fig. 10) . The rise in blood glucose concentration was more rapid, pronounced and sustained. The peak value was recorded at the 120th min and amounted to 348.5 35.0 mg/ 100 ml (p < 0.05). Thereafter, a slow decrease was noticed, eventually reaching at the 180th min a value of 245.0 21.3 mg/100 ml. This concentration was higher than that recorded at time ±5 min and at the 180th min in control experiments or after diazoxide injection (p < 0.05 in each case). 
Discussion
In an attempt to develop original K ATP channel modulators interfering with the insulin secretory process, we recently synthesised numerous diazoxide derivatives. Among the different compounds, BPDZ 73 proved to be an effective inhibitor of insulin secre- tion. The present data clearly show that in vitro BPDZ 73 provoked a concentration-dependent inhibition of insulin release from rat pancreatic islets incubated in the presence of insulinotropic glucose concentrations. Moreover, and according to the IC 50 values, BPDZ 73 seemed to be about 35 times more potent than diazoxide at reducing the glucose-induced insulin release. This higher capacity of BPDZ 73 to inhibit insulin output was confirmed by our in vivo investigations indicating that the drug provoked a pronounced increase in blood glucose concentration whereas diazoxide induced a modest, less-sustained rise in glycaemia.
Different experimental approaches showed that the inhibitory effect of BPDZ 73 on the insulin-releasing process resulted from a decrease in Ca 2+ entry following K ATP channel activation.
Radioisotopic experiments conducted on prelabelled and perifused rat pancreatic islets, an experimental procedure which has the potential advantage of preserving the complex intercellular interactions [11] , showed that BPDZ 73 elicited a concentrationdependent increase in 86 Rb outflow. This finding indirectly indicates that the drug provokes an increase in membrane K + permeability [11, 17, 29] . The 86 Rb efflux techniques also provide information about the type of K + channel affected by BPDZ 73. Thus, the BPDZ 73-induced rise in 86 Rb outflow was abolished by glibenclamide, a hypoglycaemic sulphonylurea known to close the K ATP channel [10, 30] . The increase in 86 Rb FOR was, however, more pronounced in the presence of 5.6 mmol/l than in the presence of 16.7 mmol/l glucose in the physiological medium, a feature reminiscent of the effects of different K ATP channel openers on 86 Rb outflow from pancreatic islets [11, 17, 29] . These data, as well as the close similarities between the effects of BPDZ 73 and diazoxide on 86 Rb-loaded pancreatic islets [16, 29] suggest that BPDZ 73 activates K ATP channels in islet cells.
The opening of K ATP channels, which regulate membrane potential and control-cell excitability, might be expected to hyperpolarise the beta-cell membrane. In agreement with such a view, measurements of DiBAC 4 (3) fluorescence showed that BPDZ 73 induced a concentration-dependent hyperpolarisation of the membrane potential.
It must be emphasised that, whatever the experimental protocol used, BPDZ 73 was about 35 times more potent than diazoxide at hyperpolarising the plasma membrane from b-TC3 cells and at reducing insulin output from whole pancreatic islets. Ca [14] . This increase in 45 Ca outflow was clearly sensitive, in a concentration-related manner, to the Ca 2+ channel blocker verapamil [28] but was resistant to BPDZ 73. Moreover, BPDZ 73 also failed to affect the increase in [Ca 2+ ] i elicited by a high K + concentration. These results indicate that BPDZ 73 does not directly interact at the level of the voltage-sensitive Ca 2+ channels and confirm our hypothesis that the primary action of the compound is to raise the K + permeability of the beta-cell plasma membrane.
Note that, under the different in vitro experimental conditions, the effects of BPDZ 73 were always clearly reversible. Such a feature implies that the responses to the drug were not caused by any damage to insulin-secreting cells.
Lastly, measurements of smooth muscle contractile activity in rat aortic rings showed that BPDZ 73 was slightly less potent than diazoxide at inhibiting the mechanical responses evoked by K + depolarisation. According to the EC 50 (contractile activity in aortic rings):IC 50 (insulin release from pancreatic islets) ratio, BPDZ 73 seemed to be more selective for the insulin-secreting cells than diazoxide.
The data presented here indicate that in insulin-secreting cells the compound BPDZ 73 activates K ATP channels and hyperpolarises the plasma membrane. The activation of K ATP channels responsible for repolarisation restricts the opening of voltage-sensitive Ca 2+ channels, decreases Ca 2+ inflow, reduces the cytosolic Ca 2+ concentration and, ultimately, inhibits the insulin secretory rate. We describe a new K ATP channel opener that is 35 times more potent than diazoxide on insulin-secreting cells. Moreover, and by contrast to diazoxide, this new compound seemed to have some selectivity for the pancreatic endocrine tissue compared with the vascular smooth muscle tissue. The in vitro and in vivo effectiveness of BPDZ 73 calls for further pharmacomodulation of 7-halogenosubstituted benzothiadiazine dioxides to identify new chemical entities with a powerful, and hopefully selective, biological activity on pancreatic beta cells. Such compounds could be expected to be valuable drugs in different therapeutical applications including the treatment of hyperinsulinaemia-induced hypoglycaemia in adults and children and the preservation of beta-cell function in autoimmune diabetes.
